[1]
“Cost-Effectiveness Analysis of Budesonide/Formoterol and Fluticasone/Salmeterol for Stable Chronic Obstructive Lung Disease”, J Respirol Indones, vol. 42, no. 4, pp. 289–297, Oct. 2022, doi: 10.36497/jri.v42i4.378.